+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Virtus LifeSci Biotech Clinical Trials ETF

BBCARCA

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$28.64

0.853.07%

At Close: -

15 minutes delayed

News

Holdings Dividends Short Interest

Latest news for Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC)

Virtus LifeSci Biotech Clinical Trials ETF (ARCA: BBC)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, July 12, 2024

Inflation Cools in June, Triggers Spike in Laggard ETFs
Zacks

Thursday, May 16, 2024

Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk

Tuesday, June 30, 2020

3 ETFs With Q2 Gains Of At Least 30%
ETF Professor

Thursday, May 07, 2020

3 Biotech ETFs Up 10% Or More Over The Last Month
ETF Professor

Saturday, December 28, 2019

5 Best ETFs Of 2019
ETF Professor

Monday, December 09, 2019

There's A Really Good Chance You Missed One Of The Year's Best ETFs
ETF Professor

Friday, October 06, 2017

Life (Science) Lessons: The Hows And Whos To Play Biotech
Benzinga

Friday, December 30, 2016

2016's Worst ETFs: International Illness And Healthcare Sickness
Benzinga

Monday, January 04, 2016

Paul Yook: Why I'm Optimistic About Biotechs
Benzinga
Anne-Marie Baiynd On Facebook, Disney And Looking Beyond Price
Benzinga

Thursday, August 27, 2015

ETFs BBP, BBC, TUTT Halted; Bank of NY Mellon...
Benzinga
Tuttle Tactical Mgmt US Core ETF, BioShares B...
Benzinga

Sunday, May 03, 2015

The Best (And Worst) ETFs Of Last Week Amid Social Media's Collapse
Benzinga

Saturday, March 28, 2015

Best And Worst ETFs Of The Week Amid Slowing Corporate Profits
Benzinga

Monday, January 26, 2015

Virtus Investment Partners to Acquire Majority Stake in ETF Issuer Solutions
Benzinga

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved